Thus, these findings indicate that MSTRG.81401 shRNA may alleviate the pain and depression-like behaviors in rats with comorbid DNP and MDD by suppressing the pyroptosis-inflammation pathway in hippocampal cells through downregulating P2X7. Here, P2RX7 is linked to depressive symptom measurement.